gabapentin and fk1706
gabapentin has been researched along with fk1706 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Matsuoka, N; Murai, N; Mutoh, S; Price, RD; Yamaji, T; Yamamoto, H; Yamazaki, S | 1 |
Other Studies
1 other study(ies) available for gabapentin and fk1706
| Article | Year |
|---|---|
FK1706, a novel non-immunosuppressive immunophilin ligand, modifies the course of painful diabetic neuropathy.
Topics: Amines; Analgesics; Animals; Cyclohexanecarboxylic Acids; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dose-Response Relationship, Drug; Gabapentin; gamma-Aminobutyric Acid; Immunohistochemistry; Immunophilins; Ligands; Male; Pain; Pain Measurement; Physical Stimulation; Rats; Rats, Sprague-Dawley; Tacrolimus | 2008 |